Algert Global LLC Grows Position in Balchem Co. (NASDAQ:BCPC)

Algert Global LLC grew its position in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 88.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 17,781 shares of the basic materials company's stock after purchasing an additional 8,360 shares during the quarter. Algert Global LLC owned approximately 0.05% of Balchem worth $3,129,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. O Shaughnessy Asset Management LLC bought a new position in Balchem during the 1st quarter worth approximately $321,000. Bessemer Group Inc. grew its position in shares of Balchem by 568.9% in the 1st quarter. Bessemer Group Inc. now owns 301 shares of the basic materials company's stock worth $47,000 after buying an additional 256 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Balchem by 32.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 193,146 shares of the basic materials company's stock worth $29,929,000 after buying an additional 47,036 shares during the last quarter. Janus Henderson Group PLC grew its position in shares of Balchem by 21.3% in the 1st quarter. Janus Henderson Group PLC now owns 18,059 shares of the basic materials company's stock worth $2,795,000 after buying an additional 3,176 shares during the last quarter. Finally, Tidal Investments LLC bought a new stake in shares of Balchem in the 1st quarter worth approximately $265,000. 87.91% of the stock is currently owned by institutional investors.

Balchem Stock Down 0.2 %

Shares of NASDAQ BCPC traded down $0.37 during mid-day trading on Tuesday, hitting $182.32. 96,924 shares of the stock traded hands, compared to its average volume of 110,144. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 2.98. The stock has a fifty day moving average price of $174.05 and a 200-day moving average price of $166.90. Balchem Co. has a 52 week low of $120.87 and a 52 week high of $186.03. The company has a market cap of $5.93 billion, a price-to-earnings ratio of 48.74, a PEG ratio of 5.45 and a beta of 0.65.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on BCPC. StockNews.com upgraded Balchem from a "hold" rating to a "buy" rating in a research report on Monday, October 28th. HC Wainwright raised their target price on Balchem from $185.00 to $190.00 and gave the company a "buy" rating in a research note on Monday, November 4th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.